The effects of oestrogens and anti-oestrogens on cognition

Breast

Volumn 10, Issue 6, 2001, Pages 484-491

  Shilling, V ^a   Jenkins, V ^a   Fallowfield, L ^a   Howell, A ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ALZHEIMER DISEASE; ARTICLE; ATTENTION; BREAST CANCER; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; PILOT STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; VERBAL MEMORY;

EID: 0035216746     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2001.0311     Document Type: Article

References (50)

1. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: An in situ hybridization study
2. Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area
3. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats
4. Estrogen affects performance of ovariectomized rats in a two-choice water-escape working memory task
5. Ovarian steroids and the brain: Implications for cognition and aging
6. Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatment
7. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factors
8. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause
9. Hormonal influences on morphology and neuropeptide gene expression in the infundibular nucleus of postmenopausal women
10. Gonadal hormones and cognitive performance
11. Estrogen-related cognitive abilities across the menstrual cycle
12. Post-menopausal estrogen and prevention bias
13. Effects of estrogen on memory function in surgically menopausal women
14. Estrogen use and verbal memory in healthy post-menopausal women
15. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
16. Postmenopausal hormone therapy and cognitive function in healthy older women
17. Estrogen replacement therapy and longitudinal decline in visual memory
18. Cognitive function in nondemented older women who took estrogen after menopause
19. Replacement therapy with piperazine oestrone sulfate (Harmogen) and its effects on memory
20. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females
21. A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women
22. The influence of estrogen on the psyche in climacteric and post-menopausal women
23. Estrogen improves psychological function in asymptomatic postmenopausal women
24. The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature
25. Serum estrogen levels, cognitive performance and risk of cognitive decline in older community dwelling women
26. Sex hormones and psychological functioning in postmenopausal women
27. Estrogen deficiency and risk of Alzheimer's disease in women
28. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and non-demented control subjects
29. Effects of oestrogen during menopause on risk and age of onset of Alzheimer's disease
30. Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease
31. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Balitimore Longitudinal Study of Aging
32. A case-control study of Alzheimer's disease
33. Estrogen for Alzheimer's disease in Women
34. Effects of oestrogen on cognition, mood and cerebral blood flow in AD a controlled study
35. Chemotherapy and cognitive deficits in cancer patients
36. Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients
37. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High dose versus standard dose chemotherapy
38. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
39. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
40. Age and extent of surgery affect attention in women treated with breast cancer
41. Tamoxifen prevents the skeletal effects of hormonal deficiency in rats
42. Tamoxifen therapy in early breast cancer: Biology, efficacy and side effects
43. Suppression of mouse mamary tumorigenesis by long-term tamoxifen therapy
44. Estrogen agonist effects of selective estrogen receptor modulators in ovariectomised rat brain (Abstract)
45. A randomized clinical trial evaluating tamoxifen treatment in patients with node-negative breast cancer who have estrogen-receptor-positive tumors
46. Symptoms associated with tamoxifen treatment in postmenopausal women
47. A controlled trial of raloxifene (LY139481) HCI: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
48. Raloxifene hydrochloride, a seletive estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women
49. Effect of raloxifene on cognitive function of postmenopausal women without dementia
50. Raloxifene: Cognitive-enhancing effects for postmenopausal women with AD